Cargando…

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli

OBJECTIVE: To analyze the clinical and economic impact of an antimicrobial stewardship program (ASP) targeting urinary tract infections (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. METHODS: An observational retrospective study that included adults with a diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteve-Palau, Erika, Grau, Santiago, Herrera, Sabina, Sorlí1, Luisa, Montero, Milagro, Segura, Concha, Durán, Xavier, Horcajada, Juan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2018
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159366/ https://www.ncbi.nlm.nih.gov/pubmed/29521484

Ejemplares similares

Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study
por: Rozenkiewicz, Dawid, et al.
Publicado: (2021)

Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa
por: Sorlí, Luisa, et al.
Publicado: (2017)

Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?
por: Montero, María Milagro, et al.
Publicado: (2020)

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
por: Sorlí, Luisa, et al.
Publicado: (2013)

Ceftolozane-tazobactam: When, how and why using it?
por: López, Inmaculada, et al.
Publicado: (2021)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
por: Sorli, Luisa, et al.
Publicado: (2019)

Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study
por: López Montesinos, Inmaculada, et al.
Publicado: (2021)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
por: Ranjan, K. P., et al.
Publicado: (2014)

Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Cho, Sung-Yeon, et al.
Publicado: (2016)

Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections
por: Wong, Carrie P., et al.
Publicado: (2021)

Extended spectrum beta-lactamase urinary tract infections
por: Aboumarzouk, Omar M.
Publicado: (2014)

Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli
por: Ríos, Esther, et al.
Publicado: (2022)

ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa
por: Puig-Collderram, Berta, et al.
Publicado: (2022)

Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
por: Peralta, Galo, et al.
Publicado: (2012)

Extended-Spectrum Beta-Lactamase Producing-Escherichia coli Isolated From Irrigation Waters and Produce in Ecuador
por: Montero, Lorena, et al.
Publicado: (2021)

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence
por: Lopez-Montesinos, Inmaculada, et al.
Publicado: (2022)

Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli in Cusco, Peru
por: Loyola, Steev, et al.
Publicado: (2021)

Persistent Extended-Spectrum β-Lactamase Urinary Tract Infection
por: DeBusscher, Joan, et al.
Publicado: (2009)

Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: TÜZÜN, Türkan, et al.
Publicado: (2019)

Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates
por: Montero, María Milagro, et al.
Publicado: (2022)

Corrigendum: Extended-Spectrum Beta-Lactamase Producing-Escherichia coli Isolated From Irrigation Waters and Produce in Ecuador
por: Montero, Lorena, et al.
Publicado: (2022)

Genetic Background of Escherichia coli and Extended-spectrum β-Lactamase Type
por: Branger, Catherine, et al.
Publicado: (2005)

Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
por: Han, Seung Beom, et al.
Publicado: (2015)

Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection
por: Keshi, Lu, et al.
Publicado: (2019)

Guillain-Barré Syndrome Following an Extended-Spectrum Beta-Lactamase Escherichia coli Urinary Tract Infection: A Case Report
por: Fischer, Aaron, et al.
Publicado: (2021)

Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase–Producing Escherichia coli Urinary Tract Infections in France
por: Paumier, Adeline, et al.
Publicado: (2022)

Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection
por: Kunz Coyne, Ashlan J., et al.
Publicado: (2021)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
por: Echeverría-Esnal, Daniel, et al.
Publicado: (2021)

Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time
por: Picozzi, Stefano C. M., et al.
Publicado: (2014)

Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya
por: Abujnah, Abubaker A., et al.
Publicado: (2015)

Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections
por: Spadafino, Joseph T, et al.
Publicado: (2014)

Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species
por: Koksal, Eda, et al.
Publicado: (2019)

Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review
por: Larramendy, Stéphanie, et al.
Publicado: (2020)

Antibiotic Resistance Pattern of Extended Spectrum Beta Lactamase Producing Escherichia coli Isolated From Patients With Urinary Tract Infection in Morocco
por: Kettani Halabi, Mohamed, et al.
Publicado: (2021)

In Vitro Activity of Omadacycline and Comparator Antibiotics against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Urinary Isolates
por: Stone, Tyler J., et al.
Publicado: (2023)

Extended-Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
por: Johnson, James R.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nrvv2sdba1v8kt42r3s54n1sip